Mike Hann
Mike Hann completed his PhD on Isosteric replacement studies in Enkephalins in 1980 and then worked as a medicinal chemist at Wyeth and then GD Searle in the UK. Around 1983 Mike developed an interest in computational chemistry which was then emerging as a new technique to aid drug discovery. In 1986 Mike joined Glaxo as a computational chemist. After various mergers Mike became Director of Computational Chemistry for GSK in the UK and more recently Director of Biomolecular Structure with a department that includes Protein Crystallography, Biophysics and Protein MS. Throughout this time Mike has maintained a strong interest in both lead generation and optimisation and how we can use both experimental and theoretical methods to understand the molecular mode of action of compounds.
Abstracts this author is presenting:
